More recently, the anaphase promoting complex (APC) activator CDC20 has been found to mediate the degradation of PHD3 in HCC cells, ultimately increasing the stability and activity of HIF-1α [100]. The gene discussed is HIF1A; the disease is hepatocellular carcinoma.